Research paperSynthesis and biological evaluation of a novel β-D-2′-deoxy-2′-α-fluoro-2′-β-C-(fluoromethyl)uridine phosphoramidate prodrug for the treatment of hepatitis C virus infection

Add time:08/25/2019    Source:sciencedirect.com

A novel β-D-2′-deoxy-2′-α-fluoro-2′-β-C-(fluoromethyl)uridine phosphoramidate prodrug (1) has been synthesized. This compound exhibits submicromolar-level antiviral activity in vitro against HCV genotypes 1b, 1a, 2a, and S282T replicons (EC50 = 0.18–1.13 μM) with low cytotoxicity (CC50 > 1000 μM). Administered orally, prodrug 1 is well tolerated at doses of up to 4 g/kg in mice, and produces a high level of the corresponding triphosphate in rat liver.

We also recommend Trading Suppliers and Manufacturers of 9-(4-hydroxy-2-(hydroxymethyl)butyl)-guanine triphosphate (cas 117191-32-9). Pls Click Website Link as below: cas 117191-32-9 suppliers

Prev:Asymmetric synthesis of anti-diastereoisomers of β-heterocycle substituted (S)-α-aminobutyric acids
Next:Asymmetric synthesis of hydroxy-skipped bishomo-inositols as potential glycosidase inhibitors)